Firm News and Insights | Double Helix Law | Life Sciences Intellectual Property

News & Insights

The AMRN story - Value of U.S. Biopharma Patents

The $AMRN/Vascepa story... A sad 🥲 but insightful🤔 story about the value of U.S. biopharma patents From ~$23/share to ~$1/share in ~5...

FDA/USPTO Web Sites List Patent Term Extension (PTE) Applications & Grants

If you are interested in learning more about prior patent term extension filings, the USPTO and FDA provide some helpful links, which are...

April, 11, 2023 - Double Helix Law News

DHL is excited to announce the launch of the new doublehelixlaw.com. The new site more clearly conveys info about our high-quality,...

Amgen v. Sanofi - Biotech Enablement - Sup Ct. Oral Args Tomorrow

March 26, 2023 The U.S. Supreme Court will hear oral arguments tomorrow in Amgen v. Sanofi, an important biotech enablement case. The...